4//SEC Filing
GIVEN DOUGLAS B 4
Accession 0001628280-23-016560
CIK 0000879407other
Filed
May 7, 8:00 PM ET
Accepted
May 8, 6:29 PM ET
Size
7.5 KB
Accession
0001628280-23-016560
Insider Transaction Report
Form 4
GIVEN DOUGLAS B
Director
Transactions
- Sale
Common Stock
2023-05-05$40.90/sh−6,500$265,850→ 117,635 total
Holdings
- 12,500(indirect: By Trust)
Common Stock
- 13,000(indirect: By Trust)
Common Stock
Footnotes (4)
- [F1]The price reported on Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $40.59 to $41.22, inclusive. The reporting person undertakes to provide to Arrowhead Pharmaceuticals, Inc., any security holder of Arrowhead Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote of this Form 4.
- [F2]Includes previously reported shares of common stock underlying Restricted Stock Units granted to the reporting person which are subject to certain vesting conditions.
- [F3]Represents securities owned directly by Anne Given Trust ("AG Trust"). Douglas Given, as co-trustee of AG Trust, may be deemed to beneficially own the securities owned directly by AG Trust.
- [F4]Represents securities owned directly by Katherine Given Ligtenberg Trust ("KGL Trust"). Douglas Given, as co-trustee of KGL Trust, may be deemed to beneficially own the securities owned directly by KGL Trust.
Documents
Issuer
ARROWHEAD PHARMACEUTICALS, INC.
CIK 0000879407
Entity typeother
Related Parties
1- filerCIK 0001156207
Filing Metadata
- Form type
- 4
- Filed
- May 7, 8:00 PM ET
- Accepted
- May 8, 6:29 PM ET
- Size
- 7.5 KB